Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3018 (03-018))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-Covid-19 & SARS-CoV Nucleoprotein (Clone CR3009 (03-009))
Applications | ELISA, IF |
Reactivities | SARS-CoV |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
Applications | ELISA, IF |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
Applications | ELISA, IF |
Recombinant Anti-COVID-19 & SARS-CoV S glycoprotein (Clone CR3022)
Applications | ELISA, IF |
Recombinant Anti-RSV (Clone RSHZ19 (Felvizumab))
Applications | ELISA, FN |
Reactivities | Respiratory Syncytial Virus |
Recombinant Anti-CD64 (Clone H22)
Applications | CT, FC |
Reactivities | Human |
Recombinant Anti-Integrin alpha 4 (Clone Natalizumab)
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-OX40L (Clone R4930 (Oxelumab))
Applications | Bl, FC |
Reactivities | Human |
Recombinant Anti-GM2 ganglioside (Clone L55-81)
Applications | ELISA, IHC |
Reactivities | Human |
Recombinant Anti-Fas (Clone R-125224)
Applications | ELISA, FC |
Reactivities | Human |
Anti-TIGIT [AET2010], Human IgG1, lambda
Applications | ELISA, FC |
Reactivities | Human |